Nayeli Goreti Nieto-Velázquez (Nayeli G Nieto-Velázquez)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

End Stage Renal Disease

Silver Nanoparticles

Helicobacter Pylori

Top Venues

Pathogens (Basel, Switzerland)

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Judit Alarcón-Millán, José Bonilla-Delgado, Gloria Fernández-Tilapa, Nayeli Goreti Nieto-Velázquez, Mónica Sierra-Martínez, Víctor Manuel Alvarado-Castro, Enoc Mariano Cortés-Malagón
Helicobacter pylori Virulence Factors and Clarithromycin Resistance-Associated Mutations in Mexican Patients. Pathogens (Basel, Switzerland) 12 (2) (2023)
Judit Alarcón-Millán, José Bonilla-Delgado, Gloria Fernández-Tilapa, Nayeli Goreti Nieto-Velázquez, Mónica Sierra-Martínez, Víctor Manuel Alvarado-Castro, Enoc Mariano Cortés-Malagón
Helicobacter pylori Virulence Factors and Clarithromycin Resistance-Associated Mutations in Mexican Patients. Pathogens (Basel, Switzerland) 12 (2) (2023)
Emilio Mariano Durán-Manuel, Juan Manuel Bello-López, Aranza Denisse Salinas-Bobadilla, Cruz Vargas-De-León, Nayeli Goreti Nieto-Velázquez, Mario Adán Moreno-Eutimio, Rodolfo Pastelin-Palacios, Claudia Camelia Calzada-Mendoza, Dulce Milagros Razo Blanco-Hernández
Molecular Characterization of Bacterial Agents Causing External Ocular Infections Isolates of Patients in a Third Level Hospital. Pathogens (Basel, Switzerland) 12 (11) (2023)
Judit Alarcón-Millán, José Bonilla-Delgado, Gloria Fernández-Tilapa, Nayeli Goreti Nieto-Velázquez, Mónica Sierra-Martínez, Víctor Manuel Alvarado-Castro, Enoc Mariano Cortés-Malagón
Helicobacter pylori Virulence Factors and Clarithromycin Resistance-Associated Mutations in Mexican Patients. Pathogens (Basel, Switzerland) 12 (2) (2023)
Nayeli Goreti Nieto-Velázquez, Alejandra A Gomez-Valdez, Marisela González-Ávila, Jaime Sánchez-Navarrete, Julia D Toscano-Garibay, Nancy J Ruiz-Pérez
Preliminary Study on Citrus Oils Antibacterial Activity Measured by Flow Cytometry: A Step-by-Step Development. Antibiotics (Basel, Switzerland) 10 (10) (2021)